#SPONSOR

Sponsorship View Description

#101

101: Anti-Kickback Statute Case Studies and OIG’s Regulatory Flexibilities During the COVID-19 Pandemic Benjamin Wallfisch, Senior Counsel, Industry Guidance Branch, U.S. Department of Health and Human Services, Office of Counsel to the Inspector General Susan Edwards, Industry Guidance Branch-Chief, Office of Inspector General, U.S. Department of Health and Human Services View Description

• Review challenging real-world scenarios applying the anti-kickback statute
• Understand OIG’s pandemic-related regulatory flexibilities and guidance
• Awareness of OIG’s COVID-19 strategic goals

Intermediate

#102

102: False Claims Act Liability in Post-Acute Care Claudia Reingruber, Shareholder, Saltmarsh, Cleaveland & Gund Tamar Abell, CEO, TBA Consultant William Mathias, Shareholder, Baker Ober Health Law View Description

• A review of recent False Claims Act cases, both civil and criminal, and current enforcement focus areas in Medicare for SNF, home health and hospice providers
• Challenges facing post-acute providers, including those associated with new payments systems and regulatory requirements, and new claim audit initiatives
• Current enforcement trends, including potential liability for providers and management, sources of data to manage risk, expectations from CMS that providers have effective compliance programs, and enhanced focus on “worthless care” concerns

Intermediate

#103

103: Preventing Enforcement Actions in Clinical Research - Operational Strategies for Avoiding Financial Frauds Katherine Cohen, Chief Compliance Officer, Southern Illinois University Medicine Sarah Couture, Managing Director, Ankura Consulting Group View Description

• Billing errors in Clinical Research can and have resulted in large settlements arising from False Claims Act violations
• Accurate billing for research activities is dependent on an multi-step process involving numerous players, departments, and functions. Breakdowns at any point in the process can result in large fines, settlements, and CIAs
• This presentation will show how successful clinical research billing (CRB) revolves around ensuring your clinical research operations team is effectively communicating and that the rules are properly interpreted and applied

Advanced

#201

201: Managed Care Enforcement and Compliance Benjamin Singer, Partner, O’Melveny & Myers LLP Barbara Fonte, Vice President of Managed Care and Population Health, Jackson Health System Sarah Kessler, Senior Counsel, HHS-OIG Pamela Brecht, Attorney/Partner, Pietragallo Gordon Alfano Bosick & Raspanti, LLP View Description

• Consider examples of managed care fraud using past enforcement actions as a guide
• Recognize compliance risks in managed care
• Design & Implement bi-directional education & training between Managed Care and Compliance

Basic

#202

202: How OIG Uses Data in its Affirmative Cases & How Data Can be Incorporated into Compliance Geoffrey Hymans, Senior Counsel, Office of Inspector General, US Health and Human Services Barry Grosse, V.P., Audit, Compliance, Ethics & Risk Mgmt. & CCO, Augusta University View Description

• Learn how the OIG uses data to develop affirmative Civil Monetary Penalty Law and Exclusion cases
• Learn how data can be used in unorthodox ways, such as to prove knowledge, or in quality-of-care cases
• Learn how both large and small entities can incorporate data analysis into their compliance programs

Intermediate